Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,869,113
-$334,886 QoQ
Shares Held
77,621
-1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#999
of 2,821 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Radnor Capital Management, LLC holds $105,731,738 across 8 Drug Manufacturers - General names. PFE ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
518,900 | $66,678,650 | |
| 2 | LLY |
ELI LILLY & Co
|
9,442 | $11,325,019 | |
| 3 | JNJ |
Johnson & Johnson
|
42,628 | $10,826,233 | |
| 4 | ABBV |
AbbVie Inc.
|
28,539 | $7,181,553 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,233 | $4,565,405 | |
| 6 | AMGN |
Amgen Inc
|
6,596 | $2,388,543 | |
| 7 | PFE |
Pfizer Inc
This page
|
77,621 | $1,869,113 | |
| 8 | NVS |
Novartis AG
|
5,725 | $897,222 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,869,113 | 77,621 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,203,999 | 78,490 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,954,401 | 78,490 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,178,463 | 85,497 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,072,447 | 85,497 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,171,561 | 85,697 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $2,273,541 | 85,697 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,972,195 | 102,702 | Shares | Sole | 2024-10-30 | |
| 2024-03-31 | $2,386,694 | 86,007 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $2,558,624 | 88,872 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $2,561,951 | 77,237 | Shares | Sole | 2023-10-12 | |
| 2023-03-31 | $2,406,016 | 58,971 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $2,557,747 | 49,917 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $2,104,856 | 48,100 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $2,611,014 | 49,800 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $2,381,420 | 46,000 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,738,030 | 46,368 | Shares | Sole | 2022-01-20 | |
| 2021-06-30 | $2,008,829 | 51,298 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,858,526 | 51,298 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,888,279 | 51,298 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,882,634 | 51,298 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,530,361 | 46,800 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,445,950 | 44,300 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||